Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.09% | 20.61% | -48.97% | 16.53% | 18.02% |
| Total Depreciation and Amortization | 5.67% | -0.56% | 8.81% | 5.33% | -12.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.96% | -32.96% | 66.78% | -38.34% | 39.90% |
| Change in Net Operating Assets | 68.72% | -69.31% | -2.88% | -410.90% | -78.82% |
| Cash from Operations | 42.54% | -21.29% | -24.65% | -220.04% | -509.61% |
| Capital Expenditure | 88.01% | -723.08% | 92.16% | 48.92% | 8.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.54% | -82.05% | -129.41% | 58.54% | 25.45% |
| Cash from Investing | 85.68% | -631.50% | 90.90% | 48.99% | 9.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.33% | 7.69% | 0.00% | -8.33% | 0.00% |
| Issuance of Common Stock | -99.36% | 5,944.40% | -92.90% | -17.57% | 19,087.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.67% | -3,386.79% | 90.09% | 68.32% | -40.81% |
| Cash from Financing | -99.72% | 6,384.96% | -96.36% | 78.80% | 621.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.19% | 307.72% | -329.56% | 165.08% | 130.91% |
